Keyphrases
Acute Aortic Syndrome
9%
Adipose Tissue
9%
Age-dependent
9%
Aortic Root
18%
Aortopathy
11%
Associated Proteins
11%
Azithromycin
11%
Bicuspid Aortic Valve
18%
Biomarker Discovery
10%
Biomarker Profiling
9%
Biopsy Tissue
9%
Blackcurrant Juice
9%
Bombus Terrestris
9%
Bronchiectasis
51%
Bumblebee
18%
Cardiovascular Disease
10%
Cardiovascular Mortality
18%
Cardiovascular Risk
11%
Chronic Exposure
10%
Chronic Obstructive Pulmonary Disease
46%
Chronological Age
9%
Clinical Validity
9%
Clothianidin
13%
Columbus
9%
Constitutive Androstane Receptor
18%
Cysteine Targeting
9%
Cystic Fibrosis
16%
Cytochrome P450 1A1 (CYP1A1)
10%
Degradation Products
19%
Desmosine
100%
DHX9
9%
Disease Severity
21%
DLK1-DIO3
9%
Drug Metabolism Enzyme
18%
Elastase Activity
11%
Elastin
35%
Elastin Degradation
46%
Emphysema Progression
9%
Hazard Ratio
9%
High-resolution
11%
High-throughput
18%
Imidacloprid
15%
In Vivo Stable-isotope Labeling
9%
Isodesmosine
9%
Isotope Dilution
18%
Label-free Proteomics
11%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
46%
Liver
15%
Marfan Syndrome
20%
Mode of Action
10%
Mouse Liver
13%
MS Method
18%
Neonicotinoids
18%
Neutrophil Elastase
13%
Neutrophil Extracellular Traps
18%
Nicotinic Acetylcholine Receptor (nAChR)
11%
Non-coding RNA (ncRNA)
9%
Normal Aging
9%
Novel Pathways
18%
Nrf2 Activation
18%
Nrf2 Activator
10%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
18%
Observational Cohort Study
9%
On-line SPE-LC-MS
9%
Outcome Prediction
18%
Oxidative Stress
12%
Peptide Prediction
9%
Pharmacokinetics
10%
Placebo
10%
Pregnancy Zone Protein
9%
Prostate Cancer
14%
Proteobacteria
10%
Proteomics
17%
R-loop Formation
9%
R-loops
9%
Randomized Controlled Trial
36%
Randomized Placebo-controlled Trial
10%
Reversible Covalent
9%
Root Length
18%
Rosuvastatin
9%
Ruptured Abdominal Aortic Aneurysm (rAAA)
10%
Selective Reaction Monitoring
9%
Serum Proteome
9%
SILAC
18%
Single Ion Monitoring
11%
South Asian Women
9%
Specific Degradation
12%
Sputum
31%
Sputum Microbiome
10%
Stable Isotope Dilution
19%
Stable Isotope Labeling
13%
Tayside
10%
Tetranor PGDM
9%
Transition Design
9%
Treatment Response
14%
Turnover Rate
9%
Vascular Function
10%
Vascular Health
15%
Vitamin D Supplementation
9%
Xenobiotics
9%
Biochemistry, Genetics and Molecular Biology
All Cause Mortality
6%
Amino Acids
8%
Avidin
6%
Awareness
6%
BARD1
9%
Biomarker Discovery
12%
Biotin
9%
Blood Plasma
70%
Bombus terrestris
9%
BRCA1
9%
Bumblebee
9%
C-Terminus
6%
Cancer Cell
9%
Cholecalciferol
9%
Constitutive Androstane Receptor
9%
Cross-Link
8%
Cystic Fibrosis
19%
Desmosine
90%
Dilatation
8%
Dilution
12%
Drug Interaction
5%
Drug Megadose
6%
Drug Metabolism
18%
Elastase
9%
Elastin
64%
Enzyme
22%
Enzyme Regulation
9%
Exercise Intensity
9%
Exon
9%
Fibrillin
9%
Fusion Gene
9%
Gelatinase B
9%
HDL-Cholesterol
9%
Helicase
9%
Histone H2A
9%
Hypovitaminosis D
9%
Insulin Resistance
7%
Isotope Labeling
12%
Liquid Chromatography-Mass Spectrometry
35%
Marfan's Syndrome
11%
Mass Spectrometry
6%
Messenger RNA
9%
Metalloprotease Inhibitor
5%
Microbiome
7%
Mitochondrial Disorder
9%
MMP9
9%
Mucin
9%
N-Terminus
10%
Neutrophil Elastase
9%
Normal Human
9%
Observational Study
9%
Piper (Plant)
6%
Population Risk
9%
Protein Expression
7%
Proteome
13%
Proteomics
37%
Pulse Wave
9%
Pyridinoline
6%
Quantitative Proteomics
9%
R-Loop
9%
Randomized Controlled Trial
18%
RNA Splicing
9%
Selected Ion Monitoring
10%
Skeletal Muscle
9%
Smoking
6%
Stable Isotope Labeling by Amino Acids in Cell Culture
9%
Systolic Blood Pressure
9%
Tandem Mass Spectrometry
31%
Thiol
6%
Transcription Factor Nrf2
9%
Ubiquitin Ligase
9%
Ultraviolet Radiation
9%
Vitamin D
5%
Medicine and Dentistry
25 Hydroxyvitamin D
10%
Abdominal Aortic Aneurysm
9%
Actarit
9%
Acute Aortic Syndrome
9%
Antidiabetic Agent
9%
Aortopathy
9%
Biological Marker
45%
Biopsy Technique
9%
Body Weight
9%
Bronchiectasis
31%
Cardiovascular Disease
12%
Cardiovascular Mortality
11%
Cardiovascular Risk
9%
Cardiovascular System
7%
Chronic Fatigue Syndrome
9%
Chronic Obstructive Pulmonary Disease
25%
Coherence
9%
Colecalciferol
9%
Constitutive Androstane Receptor
9%
Coronary Artery Disease
9%
Cystic Fibrosis
14%
Desmosine
36%
Disease
13%
Disease Severity
19%
Drug Metabolism
9%
Elastin
16%
Elastography
9%
Emphysema
9%
Energy Balance
9%
Enzyme Regulation
9%
Exercise Intensity
9%
Extracellular Trap
18%
Gelatinase B
9%
Glycon
9%
Growth Differentiation Factor 15
9%
Hazard Ratio
9%
Hypoglycemia
9%
Liquid Chromatography-Mass Spectrometry
6%
Marfan Syndrome
9%
Neutrophil
18%
Nicotine Replacement Therapy
9%
Non-Alcoholic Fatty Liver Disease
9%
Nonalcoholic Fatty Liver
9%
Observational Study
10%
Placebo
14%
Pregnancy Associated Alpha2 Glycoprotein
9%
Prostate Cancer
9%
Proteomics
16%
Pulse Wave Velocity
6%
Randomized Controlled Trial
18%
Respiratory Tract Infection
9%
Seasonal Variation
9%
Selected Ion Monitoring
6%
Silo-Filler's Disease
9%
Sputum
19%
Supplementation
9%
Transcription Factor Nrf2
9%
Ultraviolet Radiation
9%
Vitamin D
11%